CoChat

MDP, a database linking drug response data to genomic information, identifies dasatinib and statins as a combinatorial strategy to inhibit YAP/TAZ in cancer cells

Open access
Taccioli, Cristian, Sorrentino, Giovanni, Zannini, Alessandro, Caroli, Jimmy, Beneventano, Domenico, Anderlucci, Laura, Lolli, Marco, Bicciato, Silvio, Del Sal, Giannino · 2015 · Oncotarget
Cited by 64

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

// Cristian Taccioli 1, * , Giovanni Sorrentino 2, 3, * , Alessandro Zannini 2, 3 , Jimmy Caroli 1 , Domenico Beneventano 4 , Laura Anderlucci 5 , Marco Lolli 6 , Silvio Bicciato 1 , Giannino Del Sal 2, 3 1 Department of Life Sciences, University of Modena and Reggio Emilia, Modena 41125, Italy 2 Laboratorio Nazionale CIB (LNCIB), Area Science Park, Trieste 34149, Italy 3 Dipartimento di Scienze della Vita, Università degli Studi di Trieste, Trieste 34149, Italy 4 Dipartimento di Ingegneria “Enzo Ferrari”, Modena 41125, Italy 5 Dipartimento di Scienze Statistiche, Bologna 40124, Italy 6 Department of Science and Drug Technology, University of Torino, Torino 10125, Italy * These authors have contributed equally to this work Correspondence to: Silvio Bicciato, e-mail: silvio.bicciato@unimore.it Giannino Del Sal, e-mail: delsal@lncib.it Keywords: cancer, targeted therapy, Hippo pathway, small molecules, pharmacogenomics Received: August 10, 2015 Accepted: October 05, 2015 Published: October 15, 2015 ABSTRACT Targeted anticancer therapies represent the most effective pharmacological strategies in terms of clinical responses. In this context, genetic alteration of several oncogenes represents an optimal predictor of response to targeted therapy. Integration of large-scale molecular and pharmacological data from cancer cell lines promises to be effective in the discovery of new genetic markers of drug sensitivity and of clinically relevant anticancer compounds. To define novel pharmacogenomic dependencies in cancer, we created the Mutations and Drugs Portal (MDP, http://mdp.unimore.it ), a web accessible database that combines the cell-based NCI60 screening of more than 50,000 compounds with genomic data extracted from the Cancer Cell Line Encyclopedia and the NCI60 DTP projects. MDP can be queried for drugs active in cancer cell lines carrying mutations in specific cancer genes or for genetic markers associated to sensitivity or resistance to a given compound. As proof of performance, we interrogated MDP to identify both known and novel pharmacogenomics associations and unveiled an unpredicted combination of two FDA-approved compounds, namely statins and Dasatinib, as an effective strategy to potently inhibit YAP/TAZ in cancer cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.5749

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

Metadata

Authors
Taccioli, C., Sorrentino, G., Zannini, A., Caroli, J., Beneventano, D., Anderlucci, L., Lolli, M., Bicciato, S., & Del Sal, G.
Venue
Oncotarget
Published
2015-10-15
Volume
6
Issue
36
Pages
38854-38865
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2173710913
Cited by
64
References
7
FWCI
4.62
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.